Table 2.
Pharmacokinetic and structural parameters of compounds.
| Compound | OB | DL | BBB | HL | RBN |
|---|---|---|---|---|---|
| Chenodeoxycholic acid | 9.03 | 0.28 | −0.94 | — | 4 |
| Quercetin | 17.93 | 0.21 | −0.77 | 14.4 | 1 |
| Genistein | 27.17 | 0.69 | −0.4 | — | 1 |
| Chrysoeriol | 28.41 | 0.27 | −0.53 | 16.31 | 2 |
| Wedelolactone | 31.69 | 0.04 | −0.45 | 9.61 | 1 |
| Tectorigenin | 35.85 | 0.27 | −0.37 | — | 2 |
| Glabridin | 46.42 | 0.81 | 0.36 | 0.03 | 1 |
| Isoarnebin 4 | 46.43 | 0.28 | −0.65 | 29.33 | 3 |
| Yohimbine | 49.6 | 0.48 | −0.02 | 9.37 | 2 |
| Fisetin | 52.6 | 0.24 | −0.69 | 15.06 | 1 |
| Rg1 | 53.25 | 0.47 | −3.41 | — | 10 |
| Gallic acid | 64.79 | 0.2 | −0.54 | 11.78 | 1 |
OB : oral bioavailability; DL : drug-likeness; BBB : blood-brain barrier; HL : half-life; RBN : number of rotatable bonds.